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Objective: We investigated oxyhemoglobin change in the prefrontal cortex (PFC) of patients 
with obsessive–compulsive disorder (OCD) who showed different responses to pharmacotherapy 
during neuropsychological tasks with near-infrared spectroscopy.
Subjects and methods: A total of 42 patients with OCD (mean age: 35.6±9.6 years, 14 men, 
28 women) and healthy control subjects (mean age: 35.4±9.7 years, 13 men, 29 women) were 
selected. Patients with OCD were divided into three groups (responders to selective serotonin-
reuptake inhibitors (SSRIs), responders to SSRIs with antipsychotics, and nonresponders to 
SSRIs and SSRIs with antipsychotics) based on pharmacological response. We investigated 
oxyhemoglobin change in the PFC of subjects during Stroop tasks and a verbal fluency test 
with near-infrared spectroscopy.
Results: Responders to SSRIs showed smaller activation compared to control subjects during 
the Stroop incongruent task and verbal fluency test, but not during the Stroop congruent task. 
In contrast, responders to SSRIs with antipsychotics showed smaller activation compared to 
control subjects during all three tasks.
Conclusion: Our results suggest that activation of the PFC during Stroop tasks might predict 
responses to pharmacotherapy of patients with OCD.
Keywords: obsessive–compulsive disorder, pharmacotherapy, near-infrared spectroscopy, 
Stroop task, verbal fluency test
Introduction
Obsessive–compulsive disorder (OCD) is characterized by obsessive ideas and 
behaviors that the patient must act on to prevent anxiety and worry about persistent, 
recurrent thoughts. OCD occurs mostly in puberty and adolescence, and the lifetime-
prevalence estimate is about 2%.1,2 Neuroimaging studies have suggested that patients 
with OCD have neurobiological abnormality in the orbitofrontal cortex, caudate 
nucleus, and thalamus. Moreover, functional magnetic resonance-imaging research 
has reported that patients with OCD show lower activation compared to controls in 
the dorsolateral prefrontal cortex and anterior cingulate cortex (ACC).3
Selective serotonin-reuptake inhibitors (SSRIs) are a well-established first-line 
pharmacological treatment for patients with OCD,4 suggesting that OCD is associated 
with abnormalities in serotonergic neurotransmission. However, 40%–60% of OCD 
patients treated with SSRIs do not have a satisfactory outcome.5 Atypical antipsy-
chotics, such as risperidone, olanzapine, quetiapine, and aripiprazole, are used as an 
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augmentation strategy for SSRIs in SSRI-resistant OCD 
patients.6,7 However, it is not clear how to predict response 
to pharmacotherapy in each OCD patient.
Our group investigated brain metabolites in OCD patients 
who showed different responses to pharmacotherapy using 
proton magnetic resonance spectroscopy.8 We found signifi-
cantly lower N-acetyl-aspartate concentrations in responders 
to SSRIs with atypical antipsychotics, but not in responders to 
SSRIs, compared to control subjects in the ACC. Therefore, 
it was suggested that a subgroup of OCD patients who 
respond to SSRIs with atypical antipsychotics have distinct 
biological abnormalities in the ACC. However, it is known 
that OCD patients show cognitive impairments across several 
cognitive domains. OCD patients show low neurocognitive 
functions on the verbal memory task, Wisconsin card-sorting 
test, tower of Hanoi, and verbal fluency test (VFT).9–11 These 
neurocognitive tasks need the functions of the PFC.
The Stroop task is a cognitive task widely used to assess 
executive function. In the Stroop task, subjects are shown a 
word of a color written in colored letters and asked to name 
the color. When the letter color disagrees with the mean-
ing of the word (incongruent task), cognitive interference 
is introduced and the subject shows more false reactions 
compared to when the letter color and the meaning of the 
word are consistent (congruent task). Previous neuroimag-
ing studies have reported the PFC and ACC to be strongly 
activated during the Stroop task.12–15 It was reported the 
ACC plays a role in detecting conflict between competing 
representations and engaging the dorsolateral PFC to resolve 
such conflict.16 The VFT is a widely used neuropsychological 
task that requires subjects to generate as many words as pos-
sible beginning with a certain letter. The VFT is associated 
with basic neuropsychological functions, such as response 
initiation and attention.
Recently, several studies reported on PFC activation in 
OCD patients during the Stroop task and VFT using near-
infrared spectroscopy (NIRS).17,18 Although these studies 
showed that oxyhemoglobin (oxy-Hb) change in PFCs of 
OCD patients during neuropsychological tests was smaller 
than those of control subjects, no study has investigated 
oxy-Hb change in PFCs of OCD patients who show differ-
ent responses to pharmacotherapy. In the present study, we 
investigated oxy-Hb change in PFCs of OCD patients who 
showed different responses to pharmacotherapy during the 
Stroop task and VFT with NIRS. We hypothesized that OCD 
patients who show different responses to pharmacotherapy 
might have some differences in hemodynamic changes during 
the Stroop test and/or the VFT.
Subjects and methods
subjects
A total of 42 OCD patients (mean age: 35.6±9.6 years, 
14 men, 28 women) were selected from outpatients of the 
Department of Psychiatry of Tokushima University Hospi-
tal. OCD patients were diagnosed by a trained psychiatrist 
according to Diagnostic and Statistical Manual of Mental 
Disorders (DSM)-5. Three patients were drug-free, and 39 
were taking psychotropic drugs, including SSRIs, atypi-
cal antipsychotics, and benzodiazepines, at the time of the 
experiment. The Yale–Brown Obsessive Compulsive Scale 
(Y-BOCS) was administered to measure the severity of OCD 
symptoms.19 Healthy control subjects (mean age: 35.4±9.7 
years, 13 men, 29 women) were selected. These were college 
students, hospital employees, or their acquaintances.
Patients were divided into three groups according to 
pharmacological response. A total of 21 patients (mean 
age: 36.29±10.62 years, six men, 15 women) with .50% 
reduction in Y-BOCS scores after treatment with SSRI 
monotherapy (pretreatment Y-BOCS score: 24.14±4.02, 
posttreatment Y-BOCS score: 8.29±2.61, t
20
=19.33; P,0.01) 
comprised group A, while 14 SSRI treatment-refractory 
patients (mean age: 35.29±7.96 years, four men, ten women) 
with .35% reduction in Y-BOCS scores after atypical anti-
psychotic augmentation treatment with an SSRI (pretreatment 
Y-BOCS score: 26.79±4.08, posttreatment Y-BOCS score: 
12.5±2.98, t
13
=14.92; P,0.01) comprised group B. Group 
A and group B patients used high-dose SSRIs (fluvoxamine 
[197.22±97.5 mg], paroxetine [35±14.62 mg], sertraline 
[96.43±47.11 mg], or escitalopram [20±0 mg]). Group B 
patients used antipsychotics (risperidone [1±0 mg], arip-
iprazole [9.5±7.02 mg], olanzapine [10±0 mg], quetiapine 
[100±0 mg], or perospirone [4±0 mg]) with ongoing SSRI. 
The rest of the patients did not show responses to either SSRI 
treatment or an antipsychotic augmentation treatment.
All subjects were right-handed, as assessed by the 
Edinburgh Handedness Inventory,20 and all subjects had their 
intellectual ability assessed by the Japanese Adult Reading 
Test.21 None of the subjects had a serious medical illness, neu-
rodevelopment disorder, or a history of head injury or any drug 
or alcohol abuse. Written informed consent was obtained from 
all subjects prior to the experiment. Experimenters were blind 
to group identities during data acquisition. The ethics commit-
tee of the University of Tokushima approved this study.
Procedure
We used the Stroop task and VFT for cognitive paradigms 
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Nirs during cognitive tasks might predict drug response in OcD
showed different responses to pharmacotherapy and control 
subjects. In the Stroop task, the words “red”, “green”, and 
“blue” were displayed on a computer screen in front of the 
subjects. In the congruent condition, the word’s semantic 
meaning was congruent with the script color (eg, the word 
“red” was printed in red). In the incongruent condition, 
the word’s semantic meaning was not congruent with the 
script color (eg, the word “red” was printed in green). For 
each task, 100 words were presented at once. Subjects were 
required to read the word color as quickly as possible. The 
investigator recorded the number of correct and incorrect 
responses. The task was presented in a block design that 
included three rest periods and two test conditions (con-
gruent and incongruent). The two test conditions were 
separated by a rest period. During the rest periods, subjects 
were instructed to look at a circle presented on the computer 
screen. The duration of each test condition and rest period 
was 30 seconds. The task was administered in the follow-
ing sequence: rest, congruent task, rest, incongruent task, 
and rest. NIRS measurements were performed throughout 
all conditions. The procedure for the Stroop task was based 
on that of Watanabe et al.22
In the VFT, the procedure consisted of a 30-second pre-
task period, 60-second VFT, and 70-second posttask period. 
During the pretask and posttask periods, subjects repeated 
the vowels (a, i, u, e, o) in Japanese. During the VFT period, 
subjects were requested to respond with as many words 
beginning with a Japanese syllable as possible. The syllables 
(first “a”, second “ki”, third “ha” were used) changed every 
20 seconds during the VFT period. NIRS measurements 
were performed throughout all conditions. The procedure 
for the VFT was based on that of Suto et al.23 The Stroop 
task was conducted first, and then after 5 minutes’ rest the 
VFT was conducted.
Nirs measurements
NIRS measurements were performed using a 24-channel 
NIRS system (ETG4000; Hitachi, Tokyo, Japan) and 
using two wavelengths of NIR light (695 and 830 nm). 
The distance between the injector and the detector was 
3 cm. Changes in oxy-Hb and deoxy-Hb were calculated 
according to the Beer–Lambert law.24 A total of 24 NIRS 
probes were placed bilaterally and symmetrically on the 
left and right hemispheres. The lowest probes were placed 
along the Fp1–Fp2 line, according to the international 10–20 
electrode-placement system for electroencephalography.
Average change in oxy-Hb during the task was analyzed 
by integral mode. Linear fitting was performed on the oxy-Hb 
before and after the task. Four areas were defined to allow 
investigation of the individual effects of the task parameters 
within different regions of NIRS measurement, in accordance 
with Watanabe et al: area 1, channels 1–4, 6, and 8; area 2, 
channels 5, 7, and 9–12; area 3, channels 15, 18, 20, 21, 23, 
and 24; and area 4, channels 13, 14, 16, 17, 19, and 22.22 
Areas 1–4 represented the left dorsolateral PFC, left ventro-
medial PFC, right ventromedial PFC, and right dorsolateral 
PFC, respectively. The average change in oxy-Hb concentra-
tion in each area was calculated. NIRS measurements were 
performed as in our previous studies.25,26 The 24 probes and 
four areas are shown in Figure 1.
Data analysis and statistics
Comparison of demographic indices among groups was 
carried out using χ2 tests, unpaired t-test, and one-way 
analysis of variance (ANOVA). Moreover, Spearman’s 
rank correlation was conducted between neuropsychologi-
cal measures and Y-BOCS scores in each group. Bonferroni 
corrections were applied to maintain an overall type I error 
rate of 0.05.
Next, Levene’s test for equality of variances was con-
ducted; independent variables were drug responsiveness 
(group A, group B, and control group), task (Stroop task 
and VFT), and area (areas 1–4). As homoscedasticity was 
not accepted, two-way ANOVA was conducted in each 
task using drug responsiveness and area as independent 
variables. The Bonferroni test was used as a post hoc 
analysis.
Finally, Levene’s test for equality of variances was 
conducted; independent variables were medication status 
(SSRI, SSRI and antipsychotic, and drug-free), task (Stroop 
task and VFT) and area (areas 1–4). As homoscedasticity 
Figure 1 Near-infrared spectroscopy measurement points (areas and channels).
Notes: area 1, channels 1–4, 6, and 8; area 2, channels 5, 7, and 9–12; area 3, 
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was not accepted, two-way ANOVA was conducted in each 
task using drug responsiveness and area as independent 
variables.
Results
Demographic indices and cognitive performance of groups 
A, B, and control are shown in Table 1. As for Stroop 
incongruent-task correct responses, one-way ANOVA 
indicated a significant main effect for groups (F
2,74
=8.34, 
P,0.01). Post hoc t-tests showed that groups A and B showed 
fewer correct responses than the control group. Between 
groups A and B, there was a significant difference in Y-BOCS 
score (t
33
=-2.62, P,0.05). There were no significant cor-
relations between Y-BOCS score and neuropsychological 
measures in group A (correct responses on Stroop congru-
ent task [r=-0.26, P=0.25], incorrect responses on Stroop 
congruent task [r=0.2, P=0.38], correct responses on Stroop 
incongruent task [r=-0.18, P=0.44], incorrect responses on 
Stroop incongruent task [r=-0.2, P=0.38], and total score 
on VFT [r=-0.31, P=0.17]) or group B (correct responses 
on Stroop congruent task [r=0, P=1], incorrect responses on 
Stroop congruent task [r=-0.24, P=0.4], correct responses 
on Stroop incongruent task [r=-0.04, P=0.9], incorrect 
responses on Stroop incongruent task [r=-0.15, P=0.6], and 
total score on VFT [r=0.14, P=0.63]).
As for the Stroop congruent task, the 3×4 ANOVA for 
change in oxy-Hb concentration indicated a significant main 
effect for diagnosis (F
2,296
=8.49, P,0.01). Post hoc t-tests 
showed that group B showed a smaller change in oxy-Hb 
than the control group. As for the Stroop incongruent task, the 
3×4 ANOVA for change in oxy-Hb concentration indicated 
a significant main effect for the diagnosis (F
2,296
=10.6, 
P,0.01). Post hoc t-tests showed that groups A and B showed 
a smaller change in oxy-Hb than the control group. As for the 
VFT, the 3×4 ANOVA for change in oxy-Hb concentration 
indicated a significant main effect for diagnosis (F
2,296
=5.08, 
P,0.01) and area (F
3,296
=4.49, P,0.01). Post hoc t-tests 
showed that groups A and B showed smaller changes in 
oxy-Hb than the control group, and that area 1 had a greater 
change in oxy-Hb than area 2 or area 3. Moreover, area 4 had 
a greater change in oxy-Hb than area 3. The oxy-Hb change 
in groups during Stroop tasks and the VFT are shown in 
Table 2 and Figure 2.
To investigate the influence of medication, the OCD 
group was divided according to medication at the time 
of the experiment into patients using SSRI (mean age: 
35.39±11.51 years, five men, 13 women), those using SSRI 
and an antipsychotic (mean age: 35.29±7.96 years, four 
men, ten women), and those not using any drug (mean age: 
41.67±2.52 years, one man, two women). The 3×4 ANOVA 
was conducted for each task, and independent variables were 
medication status when NIRS were measured (patients using 
SSRIs, those using SSRIs and antipsychotics, and those 
without medication), and area (areas 1–4). There was no 
main effect of group. Regarding cognitive performances, 
correct responses on Stroop congruent task (F
2,32
=286.78, 
P=0.21), incorrect responses on Stroop congruent task 
(F
2,32
=0.2, P=0.48), correct responses on Stroop incongru-
ent task (F
2,32
=8.26, P=0.92), incorrect responses on Stroop 
incongruent task (F
2,32
=0.98, P=0.39), and total VFT score 
(F
2,32
=29.39, P=0.22) showed no significant differences 
among medication groups.
Table 1 Demographic characteristics and cognitive performance of subjects
Clinical variables Control Group A Group B P-value
n (male/female) 42 (13/29) 21 (6/15) 14 (4/10)
age (years), mean (sD) 35.38 (9.73) 36.29 (10.88) 35.29 (7.96)
education (years), mean (sD) 14.93 (1.9) 14 (1.82) 13.93 (1.77)
Duration of illness (years), mean (sD) 12.62 (9.74) 12.36 (11.22)
Y-BOcs, mean (sD) 10.38 (4.82) 15.07 (5.69) P,0.05a
JarT, FsiQ, mean (sD) 99.33 (21.86) 100 (10.28) 98.57 (7.3)
stroop congruent task (correct), mean (sD) 52.33 (12.38) 46.24 (10.4) 54.29 (16.5)
stroop congruent task (error), mean (sD) 0 0.19 (0.51) 0.07 (0.27)
stroop incongruent task (correct), mean (sD) 36.5 (6.3) 28.62 (10.58) 30 (7.61) P,0.01,b P,0.05c
stroop incongruent task (error), mean (sD) 0.76 (3.18) 3.52 (9.08) 0.93 (1.33)
VFT, “a” 5.33 (1.91) 4.86 (2.08) 4.57 (2.17)
VFT, “ki” 4.38 (2.08) 4.43 (1.96) 4.64 (1.28)
VFT, “ha” 4.33 (1.93) 4.48 (1.69) 4.64 (2.06)
VFT, total 14.04 (4.7) 13.76 (4.18) 13.86 (4.79)
Notes: agroup a , group B; bgroup a , control; cgroup B , control. group a are responders to ssris; group B are responders to ssris with antipsychotics.
Abbreviations: sD, standard deviation; Y-BOcs, Yale–Brown Obsessive compulsive scale (at the time of near-infrared spectroscopy measurement); JarT, Japanese adult 
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Discussion
Numerous functional neuroimaging studies in OCD have 
implicated dysfunction within frontal subcortical circuits 
(the orbitofrontal cortex, the caudate nucleus, the globus 
pallidus, and the thalamus) and the limbic region, such as 
the ACC. Furthermore, abnormalities in the PFC in OCD 
are also pointed out because current studies on OCD suggest 
that OCD patients show a broad range of neuropsychological 
dysfunction across all cognitive domains (memory, atten-
tion, flexibility, inhibition, verbal fluency, planning, and 
decision making). Okada et al showed that oxy-Hb change 
in the left lateral PFC of an OCD group was significantly 
smaller than that of a healthy control group during the Stroop 
task using 24-channel NIRS.17 In addition, Hirosawa et al 
showed that oxy-Hb change in the right lateral PFC of an 
OCD group was significantly smaller than that of a healthy 
control group during the VFT using 42-channel NIRS.18 
Our study also showed that oxy-Hb change in the PFC of 
the OCD group was significantly smaller than that of the 
healthy control group during the Stroop task and VFT by 
using 24-channel NIRS.
In this study, we divided OCD patients according to 
pharmacological response and compared the brain activa-
tion caused by Stroop tasks and the VFT. Our study showed 
that oxy-Hb changes in the PFC of responders to SSRIs and 
of responders to SSRIs with atypical antipsychotics were 
smaller than those of control subjects during the Stroop 
incongruent task and VFT. Furthermore, oxy-Hb changes 
in the PFC of responders to SSRIs with antipsychotics still 
showed smaller activation of the PFC compared to those of 
control subjects during the Stroop congruent task, although 



















































































































































































































































































































































































































































































Figure 2 Means of oxyhemoglobin changes in PFcs of OcD patients who showed 
different responses during stroop tasks and the VFT.
Notes: (A) ssri responders; (B) ssri with antipsychotic responders. error bars 
represent the standard deviation of mean oxyhemoglobin changes in PFcs. *P,0.05.
Abbreviations: PFcs, prefrontal cortices; OcD, obsessive–compulsive disorder; 
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Stroop congruent task measures speed and comprehension of 
reading,27 and Shaywitz and Shaywitz suggested that atten-
tion function plays a role in reading.28 Therefore, the Stroop 
congruent task might measure attentional function underly-
ing reading. Smaller oxy-Hb changes in the PFC during the 
Stroop congruent task might be related to a broad range of 
cognitive dysfunction in responders to SSRIs with atypical 
antipsychotics. However, there were no differences in oxy-Hb 
change in the PFC during the VFT between responders to 
SSRIs and responders to SSRIs with atypical antipsychotics. 
These results suggested that it might be possible to distinguish 
pharmacological responses of OCD patients by measuring 
levels of activation of the PFC during the two kinds of Stroop 
tasks. As there were no differences in task performances in 
the two kinds of Stroop tasks between responders to SSRIs 
and responders to SSRIs with atypical antipsychotics, NIRS 
might be more sensitive to neurological deficits than of 
task-performance levels. Although preliminary, our results 
suggest that measuring hemodynamic changes in neurocog-
nitive tests might be a biological predictor of responses to 
pharmacotherapy in OCD patients.
limitations
The current study had some limitations. First, the sample size 
was relatively small. Second, although there was no signifi-
cant difference in the ratio of male to female patients among 
the three groups, the ratio was very different. Third, the 
subjects showed relatively mild symptoms. Therefore, there 
is a possibility that our results do not reflect the characteristics 
of all OCD patients. Fourth, it is also possible that the medica-
tion may have had an influence on our findings, although we 
found no significant differences in oxy-Hb changes among 
medication statuses when NIRS was measured.
Conclusion
In this study, we found that OCD patients with different 
responses to pharmacotherapy showed different oxy-Hb 
changes in the PFC during the two kinds of Stroop tasks. 
Measurement of activations in the PFC might be useful to 
predict the response to pharmacotherapy in OCD patients.
Disclosure
The authors report no conflicts of interest in this work.
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